In the future, it would be useful to examine additional tissues as LRRK2 is involved in IBD (Jostins et al., 2012), leprosy (Zhang et al., 2009), and cancer (Ruiz-Martínez et al., 2014, Saunders-Pullman et al., 2010). This evidence concerns the gene LRRK2 and cancer.